Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Organic anion transporter 3 contributes to the regulation of blood pressure

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Vallon, V.
  • Eraly, S. A.
  • Wikoff, W. R.
  • Rieg, T.
  • Kaler, G.
  • Truong, D. M.
  • Ahn, S. Y.
  • Mahapatra, N. R.
  • Mahata, S. K.
  • Gangoiti, J. A.
  • Wu, W.
  • Barshop, B. A.
  • Siuzdak, Gary
  • Nigam, S. K.

publication date

  • September 2008

journal

  • Journal of the American Society of Nephrology  Journal

abstract

  • Renal organic anion transporters (OAT) are known to mediate the excretion of many drugs, but their function in normal physiology is not well understood. In this study, mice lacking organic anion transporter 3 (Oat3) had a 10 to 15% lower BP than wild-type mice, raising the possibility that Oat3 transports an endogenous regulator of BP. The aldosterone response to a low-salt diet was blunted in Oat3-null mice, but baseline aldosterone concentration was higher in these mice, suggesting that aldosterone dysregulation does not fully explain the lower BP in the basal state; therefore, both targeted and global metabolomic analyses of plasma and urine were performed, and several potential endogenous substrates of Oat3 were found to accumulate in the plasma of Oat3-null mice. One of these substrates, thymidine, was transported by Oat3 expressed in vitro. In vivo, thymidine, as well as two of the most potent Oat3 inhibitors that were characterized, reduced BP by 10 to 15%; therefore, Oat3 seems to regulate BP, and Oat3 inhibitors might be therapeutically useful antihypertensive agents. Moreover, polymorphisms in human OAT3 might contribute to the genetic variation in susceptibility to hypertension.

subject areas

  • Adrenocorticotropic Hormone
  • Aldosterone
  • Animals
  • Blood Pressure
  • Corticosterone
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Oocytes
  • Organic Anion Transporters, Sodium-Independent
  • Renin
  • Xenopus
scroll to property group menus

Identity

PubMed Central ID

  • PMC2518443

International Standard Serial Number (ISSN)

  • 1046-6673

Digital Object Identifier (DOI)

  • 10.1681/asn.2008020180

PubMed ID

  • 18508962
scroll to property group menus

Additional Document Info

start page

  • 1732

end page

  • 1740

volume

  • 19

issue

  • 9

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support